A new study led by BHP founder member the University of Birmingham and the University of Oxford has found the mortality rate in cancer patients who are assessed or treated … Continue reading “Anti-cancer treatments don’t affect COVID-19 mortality, finds Birmingham & Oxford”
Month: May 2020
Rare childhood cancer clinical trial to be run in UK from Birmingham
A Birmingham Health Partners team will coordinate the UK arm of a critical European clinical trial which could lead to the development of more effective, kinder treatments for children diagnosed … Continue reading “Rare childhood cancer clinical trial to be run in UK from Birmingham”
UHB joins ground-breaking new COVID-19 genomic study
BHP founder-member University Hospitals Birmingham (UHB) has begun recruiting COVID-19 patients to participate in a ground-breaking new study of the disease – aiming to identify specific genes that may explain … Continue reading “UHB joins ground-breaking new COVID-19 genomic study”
Study finds new group of lung cancer patients could benefit from immunotherapy treatment
Immunotherapy could benefit a new group of lung cancer patients, according to the results of a clinical trial which took place at BHP founder-member the University of Birmingham. Treating patients … Continue reading “Study finds new group of lung cancer patients could benefit from immunotherapy treatment”
Why does sarcoma resist immunotherapy?
Professor Andrew Beggs hopes to use the DNA of cancer cells to answer a very pressing question – why don’t sarcomas respond well to immunotherapy? Immunotherapy is a type of … Continue reading “Why does sarcoma resist immunotherapy?”